BDBM336769 4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-({2- [(methylsulfonyl)methyl] phenyl}carbonyl)piperidin-3- yl]oxy}pyridine::US9745284, 31

SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)Oc1cc(OCC(F)F)ccn1

InChI Key InChIKey=BJJJFGUBVXIICD-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 336769   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM336769(4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-({2...)
Affinity DataIC50: 34nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM336769(4-(2,2-difluoroethoxy)-2- {[(3R,6R)-6-methyl-1-({2...)
Affinity DataIC50: 1.00E+4nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
US Patent